CVS Subsidiary, RxAmerica, Reaches $5 Million
DOJ
False Claims Act
Penalty
$10 billion
Outcome
CVS Subsidiary, RxAmerica, Reaches $5 Million Settlement with US for Allegedly Submitting False Pricing Relating to the Company’s Medicare Part D Plan
Details
CVS Subsidiary, RxAmerica, Reaches $5 Million — DOJ Enforcement (2012)
Outcome: CVS Subsidiary, RxAmerica, Reaches $5 Million Settlement with US for Allegedly Submitting False Pricing Relating to the Company’s Medicare Part D Plan
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works